A second-generation Janus kinase (JAK) inhibitor for dogs, including efficacy data, safety information, and the Science of Selectivityâ„¢.
LEARN MOREFor the treatment of dogs with clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood.
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORE